Details of the Drug Formulaction

General Information of Drug Formulation (ID: F13004)

• Formulation Name: Mepenzolate 25 mg tablet
• Company: Sanofi-Aventis

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Mepenzolate	(DM8YU2F)	Gastric ulcer	DA60	Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	(E00099)	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Hydrazine yellow	(E00409)	164825	Colorant
Magnesium stearate	(E00208)	11177	lubricant
Saccharose	(E00091)	5988	Binding agent; Coating agent; Cryoprotectant; Diluent; Flavoring agent; Suspending agent; Viscosity-controlling agent